Thomas Kurian 称与默沙东的合作是技术支持制药价值链方式的根本性转变,智能体 AI 将加快药物惠及患者。
我们与默沙东的合作标志着技术支持整个制药价值链方式的根本性转变。通过部署由 Gemini Enterprise 驱动的业界首个智能体生态系统,默沙东不只是优化业务流程,而是在构建一个将 AI 的速度与人类智慧结合起来的未来,让药物更快惠及患者,并解决以往无法触及的难题。原文 (en)
Our partnership with Merck represents a fundamental shift in how technology supports the entire pharma value chain. By deploying an industry-first agentic ecosystem powered by Gemini Enterprise, Merck is not just optimizing business processes; it is building a future where the speed of AI and the expertise of human ingenuity come together to bring drugs to patients faster and solve problems that were previously out of reach.